Cargando…

Cardiovascular Disease Protection in Long-Duration Type 1 Diabetes and Sex Differences

Detalles Bibliográficos
Autores principales:	He, Zhiheng H., D’Eon, Stephanie A., Tinsley, Liane J., Fitzgerald, Shane, Hastings, Stephanie M., Khamaisi, Mogher, Sun, Jennifer K., Turek, Sara J., Schaefer, Ernst J., King, George L., Keenan, Hillary A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2015
Materias:	e-Letters: Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407756/ https://www.ncbi.nlm.nih.gov/pubmed/25908159 http://dx.doi.org/10.2337/dc15-0017

Ejemplares similares

High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
por: Maddaloni, Ernesto, et al.
Publicado: (2017)

Sexual Dysfunction as a Marker of Cardiovascular Disease in Males With 50 or More Years of Type 1 Diabetes
por: Turek, Sara J., et al.
Publicado: (2013)

Subjects With Extreme-Duration Type 1 Diabetes Exhibit No Structural or Functional Abnormality on Cardiac MRI
por: Asghar, Omar, et al.
Publicado: (2016)

Stem Cells for Diabetes Complications: A Future Potential Cure
por: Khamaisi, Mogher, et al.
Publicado: (2017)

Is there an ethnic variation in the epidemiology of gonorrhoea? A retrospective population-based study from northern Israel over 15 years between 2001 and 2015
por: Kridin, Khalaf, et al.
Publicado: (2017)

Research, adapt, and overcome: Changes in submission rates to endocrinology scientific journals during the COVID-19 pandemic
por: Noyman, Dror Ben Ephraim, et al.
Publicado: (2022)

Enumerating β-Cells in Whole Human Islets: Sex Differences and Associations With Clinical Outcomes After Islet Transplantation
por: Marchese, Enza, et al.
Publicado: (2015)

Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes
por: Rana, Jamal S., et al.
Publicado: (2021)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
por: Ryder, Robert E.J., et al.
Publicado: (2023)

Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison
por: Weisman, Alanna, et al.
Publicado: (2018)

Impact of Duration of N-Acetylcysteine in Non-Acetaminophen–Induced Acute Liver Failure
por: Bass, Stephanie N., et al.
Publicado: (2021)

Dietary Phosphatidylcholine Intake and Type 2 Diabetes in Men and Women
por: Li, Yanping, et al.
Publicado: (2015)

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
por: Crowley, Matthew J., et al.
Publicado: (2020)

Underuse of Medications and Lifestyle Counseling to Prevent Cardiovascular Disease in Patients With Diabetes
por: Newman, Jonathan D., et al.
Publicado: (2019)

High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes
por: Tang, Olive, et al.
Publicado: (2020)

Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy?
por: Heyman, Samuel N., et al.
Publicado: (2013)

Efficient conditioned pain modulation despite pain persistence in painful diabetic neuropathy
por: Granovsky, Yelena, et al.
Publicado: (2017)

Alveolar Hemorrhage Following Positron Emission Tomography/Computed Tomography in 2 Separate Episodes 5 Months Apart
por: Khateeb, Jasmin, et al.
Publicado: (2023)

Prospective Associations of Waist-to-Height Ratio With Cardiovascular Events in Postmenopausal Women: Results From the Women’s Health Initiative
por: Lo, Kenneth, et al.
Publicado: (2019)

Improving Diabetes Management and Cardiovascular Risk Factors Through Peer-Led Self-management Support Groups in Western Kenya
por: Park, Paul H., et al.
Publicado: (2015)

Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes
por: Imafuku, Tadashi, et al.
Publicado: (2021)

Observations on the Duration and Course of Fever in Britain, and on the Efficacy of Medicine in Interrupting Its Course, and in Shortening Its Duration
por: Brown, William
Publicado: (1802)

Changes in Management of Type 2 Diabetes Before and After Severe Hypoglycemia
por: Vijayakumar, Pavithra, et al.
Publicado: (2020)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Simultaneous Consideration of HbA(1c) and Insulin Resistance Improves Risk Assessment in White Individuals at Increased Risk for Future Type 2 Diabetes
por: Meigs, James B., et al.
Publicado: (2020)

An Insulin Resistance Score Improved Diabetes Risk Assessment in the Malmö Prevention Project—A Longitudinal Population-Based Study of Older Europeans
por: Shiffman, Dov, et al.
Publicado: (2021)

Predictive Value of Admission Hemoglobin A(1c) on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes
por: Pasquel, Francisco J., et al.
Publicado: (2015)

Revalidation of the Hypoglycemia Risk Stratification Tool Using ICD-10 Codes
por: Karter, Andrew J., et al.
Publicado: (2019)

The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3
por: Sridhar, Vikas S., et al.
Publicado: (2023)

Management of Diabetic Ketoacidosis in Severe Insulin Resistance
por: Robinson, Cemre, et al.
Publicado: (2016)

Benefits of Participating With a Partner in the National Diabetes Prevention Program
por: Ritchie, Natalie D., et al.
Publicado: (2020)

Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels
por: Shukla, Alpana P., et al.
Publicado: (2015)

Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium–Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy
por: Meyer, Emily J., et al.
Publicado: (2020)

Real-time Continuous Glucose Monitoring During a Hyperinsulinemic-Hypoglycemic Clamp Significantly Underestimates the Degree of Hypoglycemia
por: Farrell, Catriona M., et al.
Publicado: (2020)

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
por: Li, Guangyao, et al.
Publicado: (2019)

Degree of Cardiometabolic Risk Factor Normalization in Individuals Receiving Bariatric Surgery: Evidence From NHANES 2015–2018
por: Hong, Young-Rock, et al.
Publicado: (2021)

Images From the Exeter Archival Diabetes Biobank Now Accessible via Pancreatlas
por: Morgan, Noel G., et al.
Publicado: (2022)

Is Shelter-in-Place Policy Related to Mail Order Pharmacy Use and Racial/Ethnic Disparities for Patients With Diabetes?
por: Thomas, Tainayah W., et al.
Publicado: (2021)

The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model
por: Tomkovich, Sarah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e4bvurjifbma4uh4dlaoeag0qs